Medicare Enrolled

Dr. Lal Bhagchandani, M.D.

Pulmonary Disease · Margate, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2825 N STATE ROAD 7, Margate, FL 33063
9549174941
In practice since 2007 (19 years)
NPI: 1750438974 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bhagchandani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bhagchandani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bhagchandani

Dr. Lal Bhagchandani is a pulmonary disease in Margate, FL, with 19 years in practice. Based on federal Medicare data, Dr. Bhagchandani performed 2,776 Medicare services across 1,524 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bhagchandani received a total of $7,859 from 32 pharmaceutical and/or device companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bhagchandani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 20% volume in FL$ $7,859 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,776
Medicare services
Top 20% in FL for pulmonary disease
1,524
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~146 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity1,114$96$258
Critical care, first 30-74 min258$173$473
Initial hospital admission, high complexity228$135$362
Office visit, established patient (20-29 min)223$68$187
Office visit, established patient (30-39 min)141$96$263
Test to measure lung airway sensitivity119$44$104
Evaluation of use of breathing device119$13$45
Test to determine lung volumes using sensors119$40$98
Test to examine how well the lungs exchange gases119$43$104
Test to measure largest amount of air breathed in an out118$11$44
Hospital follow-up visit, moderate complexity71$63$173
New patient office visit (45-59 min)59$122$311
New patient office visit (30-44 min)39$88$297
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation34$73$650
Transitional care management services for problem of high complexity15$221$448
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,859
Total received (2018-2024)
Avg $1,123/year across 7 years
Top 26% in FL for pulmonary disease
32
Companies
291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,859 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$770
2023
$1,339
2022
$1,075
2021
$773
2020
$951
2019
$1,206
2018
$1,744

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,478
GlaxoSmithKline, LLC.
$1,953
Boehringer Ingelheim Pharmaceuticals, Inc.
$725
Janssen Pharmaceuticals, Inc
$479
Mylan Specialty L.P.
$268
Harmony Biosciences LLC
$233
Fisher & Paykel Healthcare Inc
$149
PFIZER INC.
$146
Bayer Healthcare Pharmaceuticals Inc.
$143
Takeda Pharmaceuticals U.S.A., Inc.
$140
La Jolla Pharmaceutical Company
$125
Lilly USA, LLC
$125
Novo Nordisk Inc
$125
Mallinckrodt Hospital Products Inc.
$83
Abbott Laboratories
$80
Paratek Pharmaceuticals, Inc.
$70
Regeneron Healthcare Solutions, Inc.
$64
Shire North American Group Inc
$53
GENZYME CORPORATION
$52
JAZZ PHARMACEUTICALS INC.
$49
Sunovion Pharmaceuticals Inc.
$46
Resmed Corp
$41
Grifols USA, LLC
$37
Insmed, Inc.
$27
Jazz Pharmaceuticals Inc.
$27
Electromed, Inc.
$25
Philips Electronics North America Corporation
$25
Nabriva Therapeutics, plc
$21
Actelion Pharmaceuticals US, Inc.
$19
Circassia Pharmaceuticals Inc
$19
Advanced Respiratory, Inc
$19
Amgen Inc.
$13
Top 3 companies account for 65.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirCurve · Allure Quadra RF CRT Pacemaker · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GIAPREZA · GLASSIA · INVOKANA · Kerendia · LONHALA MAGNAIR · Life 2000 Ventilation System · MOUNJARO · NUCALA · NUZYRA · OFEV · OPSUMIT · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PANZYGA · Prolastin-C · Prolastin-C Liquid · Quadra Assura CRT Defibrillator · Rybelsus · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Swift · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · UTIBRON NEOHALER · Utibron · WAKIX · XARELTO · Xenleta · Xyrem · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $283 per 100 Medicare services performed
Looking for a pulmonary disease in Margate?
Compare pulmonary diseases in the Margate area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
98
Per 100K population
5.0
County median income
$74,534
Nearest hospital
HCA FLORIDA NORTHWEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bhagchandani is a clinical cardiology specialist, with above-average Medicare volume (top 20% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bhagchandani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Bhagchandani performed 1,114 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bhagchandani receive payments from pharmaceutical companies?
Yes. Dr. Bhagchandani received a total of $7,859 from 32 companies across 291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bhagchandani's costs compare to other pulmonary diseases in Margate?
Dr. Bhagchandani's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bhagchandani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →